FDSVX
Price
$66.98
Change
-$0.17 (-0.25%)
Updated
Sep 5 closing price
Net Assets
6.43B
RGEBX
Price
$82.89
Change
+$0.45 (+0.55%)
Updated
Sep 8 closing price
Net Assets
332.38B
Interact to see
Advertisement

FDSVX vs RGEBX

Header iconFDSVX vs RGEBX Comparison
Open Charts FDSVX vs RGEBXBanner chart's image
Fidelity Growth Discovery
Price$66.98
Change-$0.17 (-0.25%)
VolumeN/A
Net Assets6.43B
American Funds Growth Fund of Amer R2E
Price$82.89
Change+$0.45 (+0.55%)
VolumeN/A
Net Assets332.38B
FDSVX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FDSVX vs. RGEBX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDSVX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. FDSVX (6.43B). FDSVX pays higher dividends than RGEBX: FDSVX (0.17) vs RGEBX (0.00). FDSVX was incepted earlier than RGEBX: FDSVX (27 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than FDSVX (0.66). FDSVX is a more actively managed with annual turnover of: 41.00 vs. RGEBX (25.00). FDSVX has a lower initial minimum investment than RGEBX: FDSVX (0) vs RGEBX (250). RGEBX annual gain was more profitable for investors over the last year : 20.12 vs. FDSVX (13.23). RGEBX return over 5 years is better than : 40.41 vs. FDSVX (38.07).
FDSVXRGEBXFDSVX / RGEBX
Total Expense Ratio0.661.0961%
Annual Report Gross Expense Ratio0.661.0961%
Fund Existence27 years11 years-
Gain YTD8.85515.39858%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.43B332B2%
Annual Yield % from dividends0.170.00-
Returns for 1 year13.2320.1266%
Returns for 3 years57.3449.83115%
Returns for 5 years38.0740.4194%
Returns for 10 years179.1191.53196%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMAX0.26N/A
+1.15%
Powell Max Ltd
DNLI15.510.08
+0.52%
Denali Therapeutics
FRPH25.580.11
+0.43%
FRP Holdings
CNA47.71-0.30
-0.62%
CNA Financial Corp
ARTV3.11-0.50
-13.85%
Artiva Biotherapeutics Inc